430 related articles for article (PubMed ID: 35583791)
21. The gut in Parkinson's disease: Bottom-up, top-down, or neither?
Leclair-Visonneau L; Neunlist M; Derkinderen P; Lebouvier T
Neurogastroenterol Motil; 2020 Jan; 32(1):e13777. PubMed ID: 31854093
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease.
Singh Y; Trautwein C; Romani J; Salker MS; Neckel PH; Fraccaroli I; Abeditashi M; Woerner N; Admard J; Dhariwal A; Dueholm MKD; Schäfer KH; Lang F; Otzen DE; Lashuel HA; Riess O; Casadei N
Mol Neurodegener; 2023 Jul; 18(1):44. PubMed ID: 37403161
[TBL] [Abstract][Full Text] [Related]
23. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
[TBL] [Abstract][Full Text] [Related]
24. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
[TBL] [Abstract][Full Text] [Related]
25. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
Alfonsetti M; Castelli V; d'Angelo M
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
[TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
27. Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
Liang F; Chen CY; Li YP; Ke YC; Ho EP; Jeng CF; Lin CH; Chen SK
J Parkinsons Dis; 2022; 12(8):2423-2440. PubMed ID: 36155528
[TBL] [Abstract][Full Text] [Related]
28. Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies.
Zhang X; Tang B; Guo J
Transl Neurodegener; 2023 Dec; 12(1):59. PubMed ID: 38098067
[TBL] [Abstract][Full Text] [Related]
29. Gut dysfunction in Parkinson's disease.
Mukherjee A; Biswas A; Das SK
World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond.
Brown EG; Goldman SM
Neurotherapeutics; 2020 Oct; 17(4):1406-1417. PubMed ID: 33034846
[TBL] [Abstract][Full Text] [Related]
31. The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F; Derkinderen P; Borghammer P
J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
[TBL] [Abstract][Full Text] [Related]
33. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis.
Manfready RA; Goetz CG; Keshavarzian A
Int Rev Neurobiol; 2022; 167():81-99. PubMed ID: 36427960
[TBL] [Abstract][Full Text] [Related]
34. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
35. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
Dong S; Sun M; He C; Cheng H
Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
[TBL] [Abstract][Full Text] [Related]
36. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
37. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
38. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
40. Exploring the Connection Between the Gut Microbiome and Parkinson's Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options.
Chan DG; Ventura K; Villeneuve A; Du Bois P; Holahan MR
J Parkinsons Dis; 2022; 12(8):2339-2352. PubMed ID: 36278360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
